TransCode Therapeutics, Inc. RNAZ 深 沪
已收盘 07-02 16:00:00 美东时间
8.61
+0.960
+12.55%
华盛通- 最 高8.79
- 今 开7.74
- 成交量 5.17万股
- 最 低 7.621
- 昨 收 7.65
- 总市值 818.21万
- 52周最高 20.99
- 市盈率 静 --
- 换手率 5.44%
- 52周最低 3.82
- 委 比 -22.48%
- 总股本 95.03万
- 历史最高 5174400.00
- 量 比 1.42
- 振 幅 15.28%
- 历史最低 3.82
- 每 手 1
- 风险率 2.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TransCode Highlights Progress of Lead RNA Cancer Therapeutic
An update from TransCode Therapeutics ( ($RNAZ) ) is now available. On June 18,...
06-18 20:39
EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study
TransCode Therapeutics announced successful completion of Phase 1a clinical trial for TTX-MC138, showing safety and disease stabilization in patients with advanced cancer.
06-03 19:41
TransCode启动TTX-MC138针对ctDNA阳性结直肠癌患者的2a期临床试验
临床阶段肿瘤公司TransCode Therapeutics， Inc．（纳斯达克代码：RNAZ）今日宣布，正式启动其领先候选药物TTX-MC138的2a期...
05-28 03:38
TransCode amends 8-K to add details on plan to regain Nasdaq equity compliance
TransCode amends 8-K to add details on plan to regain Nasdaq equity compliance TransCode Therapeutics amended a May 22 Form 8-K to add details on its plan to regain Nasdaq minimum stockholders’ equity compliance. Nasdaq flagged non-compliance with Listing Rule 5550(b)(1) on May 19, requiring at leas
05-26 18:44
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
An update from TransCode Therapeutics ( ($RNAZ) ) is now available. On May 19, ...
05-23 06:10
TransCode Therapeutics Q1 EPS $(21.28) Up From $(70.16) YoY
TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(21.28) per share. This is a 69.67 percent increase over losses of $(70.16) per share from the same period last year.
05-16 06:43
Transcode Therapeutics Files Prospecuts For Resale Of Up To 15,955,543 Shares By Selling Stockholders
TransCode Therapeutics, Inc.15,955,543 SharesCommon StockThis prospectus relates to the possible resale or other disposition from time to time by the selling stockholders named in this prospectus of up to an
05-01 05:35
美股夜盘 | FST Corp.涨47.54%，Kyverna Therapeutics, Inc.涨35.84%
FST Corp.涨47.54%；Kyverna Therapeutics, Inc.涨35.84%；Aspire Biopharma Holdings, Inc.涨18.85%
04-22 15:01
TransCode Therapeutics Enters Into Agreement With Institutional Healthcare Investor For Financing Of Up To $20M
TransCode Therapeutics, Inc. (NASDAQ:RNAZ, the ", Company", )), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, today announced that it has entered into an
04-07 20:37
TransCode Therapeutics Delays 2025 Annual Filing
TransCode Therapeutics ( ($RNAZ) ) has released a notification of late filing. ...
04-01 10:25
